Rheumatic Heart Disease Research from Children’s National Named Top 10 Advance in Heart Disease/Stroke Research for 2012 December 21, 2012

WASHINGTON, DC—The American Heart Association and the American Stroke Association named a study from pediatric cardiologists at Children’s National Medical Center as one of the top 10 advances in heart and stroke research for 2012. In a study published in Circulation in June, Craig Sable, MD, and Andrea Beaton, MD, found that routine screening with echocardiogram can detect three times as many cases of rheumatic heart disease as clinical examinations. The significance of this research is that it offers a novel approach in preventing a very common disease.

Rheumatic heart disease (RHD) is a significant global health problem, impacting more than 15 million people. In the study from Children’s National, the team studied more than 5,000 children in Uganda, making it the largest screening trial for RHD. The team found that the echocardiogram detected three times as many cases of rheumatic heart disease as the traditional use of only the stethoscope.

“We’re honored to have our work in pediatrics recognized by the American Heart Association and the American Stroke Association,” said Dr. Beaton, the study’s lead author. “Hopefully, this will help bring more attention to a preventable global health issue.”

The AHA has been compiling an annual list of the top 10 major advances in heart disease and stroke research since 1996. This year’s top advances mark the first time that several pediatric research advances were featured.

“We’re happy that our work with rheumatic heart disease and other important pediatric discoveries were recognized by the American Heart Association. Pediatric heart disease is an important, but easily overlooked area that impacts families throughout the world,” said Dr. Sable, a pediatric cardiologist at Children’s National and senior author.  Dr. Sable is chair of AHA Committee on Cardiovascular Disease in the Young.

RHD is the most common acquired cardiovascular disease, affecting approximately 15 million people, with a high incidence in developing countries. RHD is caused by repeated exposure to streptococcal bacteria, or strep throat, which is treated with antibiotics – when easily accessible. Repeated exposure to strep can lead to RHD, which carries many risks, including death. By identifying signs of RHD early, children can receive readily available antibiotics to prevent serious harm.

Contact: Emily Dammeyer or Emily Hartman, Children’s National Public Relations: 202.476.4500.

About Children’s National Health System

Children’s National Health System, based in Washington, DC, has been serving the nation’s children since 1870. Children���s National is ranked in the top 20 in every specialty evaluated by U.S. News & World Report; one of only four children’s hospitals in the nation to earn this distinction. Designated a Leapfrog Group Top Hospital and a two-time recipient of Magnet® status, this pediatric academic health system offers expert care through a convenient, community-based primary care network and specialty outpatient centers. Home to the Children’s Research Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National is one of the nation’s top NIH-funded pediatric institutions. Children’s National is recognized for its expertise and innovation in pediatric care and as a strong voice for children through advocacy at the local, regional and national levels. For more information, visit ChildrensNational.org, or follow us on Facebook and Twitter.

Latest Tweets